SAVEL, Helene; MEYER-LOSIC, Florence; PROUST LIMA, Cecile; RICHERT, Laura

doi:10.1038/s41598-023-51055-7

Statistics In System biology and Translational Medicine [SISTM]
Bordeaux population health [BPH]

MEYER-LOSIC, Florence
IPSEN Innovation

PROUST LIMA, Cecile

Bordeaux population health [BPH]

Langue

Article de revue

Ce document a été publié dans

Scientific Reports. 2024-01-09, vol. 14, n° 1, p. 934

Résumé en anglais

Translational oncology research strives to explore a new aspect: identifying subgroups that exhibit treatment response even during pre-clinical phases. In this study, we focus on PDX models and their implementation in mouse clinical trials (MCT). Our primary objective was to identify subgroups with different treatment responses using Latent Class Mixed Model (LCMM).We used a public dataset and focused on one treatment, encorafenib, and two indications, melanoma and colorectal cancer, for which efficacy depends on a specific mutation BRAF V600E. One LCMM per indication was implemented to classify treatment responses at the PDX level, analyzing the growth kinetics of treated tumors and matched controls within the PDX models. A simulation study was carried out to explore the performance of LCMM in this context. For both applications, LCMM identified classes for which the higher the proportion of mutated BRAF V600E PDX models the greater the treatment effect, which is aligned with encorafenib use recommendations. The simulation study showed that LCMM could identify classes with large differences in treatment effects. LCMM is a suitable tool for MCT to explore treatment response subgroups of PDX. Once these subgroups are defined, characterization of their phenotypes/genotypes could be performed to explore treatment response predictors.< Réduire

URI

https://oskar-bordeaux.fr/handle/20.500.12278/188684

DOI

http://dx.doi.org/10.1038/s41598-023-51055-7

Unités de recherche

Bordeaux Population Health Research Center (BPH) - UMR 1219

Voir/Ouvrir

Métadonnées

Partager cette publication !

Licence d’utilisation du document

Statistical classification of treatment responses in mouse clinical trials for stratified medicine in oncology drug discovery

Langue

Ce document a été publié dans

Résumé en anglais

URI

DOI

Unités de recherche